Therefore, numerous investigations are being carried out to identify potential targets such as galectin-1, cancer associated cathepsins, OX40+Foxp3+ Treg cells, etc., to develop new therapies and to achieve greater treatment efficacy. This evidence concerns the gene LGALS1 and cancer.